Physician

Internal Medicine

James Weick practices Internal Medicine. He studied medicine at The Ohio State University College of Medicine. James Weick is a published doctor as well. He has 49 publications published. The latest was: A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Sou...

Publications

---

• Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology G...
• Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study.
• N-ras mutations in adult de novo Acute myelogenous leukemia: prevalence and clinical significance.
• Unmaintained remissions in multiple Myeloma.
• Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in Acute myeloid leukemia by multiparameter flow cytometry: identificatio...
• Assessment of psychological distress in prospective bone marrow transplant patients.
• Immunophenotypic characterization of Acute leukemia by immunocytology.
• Aggressive multimodality therapy for malignant pleural mesothelioma.
• Combination chemotherapy of metastatic thyroid Cancer. Phase II study.
• Pleural effusion in Lymphoma.
• Combination therapy for multiple Myeloma.
• Phase I trial of intraperitoneal chemotherapy with 5-fluorouracil and citrovorum factor.
• 5-Fluorouracil and folinic acid: a Phase I-II trial in gastrointestinal malignancy.
• The treatment of Acute leukemia with continuous infusion L-Alanosine.
• Gallium nitrate in malignant Lymphoma: a Southwest Oncology Group study.
• Treatment of non-small cell bronchogenic carcinoma with vinblastine and mitomycin: a Southwest Oncology Group Study.
• Extensive adenocarcinoma and large cell undifferentiated carcinoma of the Lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study.
• Phase II evaluation of teniposide and ifosfamide in refractory adult Acute lymphocytic leukemia: a Southwest Oncology Group Study.
• Phase II evaluation of aclarubicin in refractory adult Acute leukemia: a Southwest Oncology Group Study.
• A Southwest Oncology Group phase II Trial of recombinant tumor necrosis factor in metastatic breast Cancer.
• Phase II study of amsacrine (m-AMSA) in advanced Lymphomas: a Southwest Oncology Group study.
• Phase II study of diaziquone in untreated advanced gastric carcinoma. A Southwest Oncology Group Study.
• Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial.
• Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.
• Effect of aggressive daunomycin therapy on survival in Acute promyelocytic leukemia.
• Estrogen receptor methylation is associated with improved survival in adult Acute myeloid leukemia.
• Treatment of Acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy.
• Colchicine in refractory chronic lymphocytic Leukemia. A Southwest Oncology Group study.
• Vindesine, carmustine, doxorubicin, and prednisone (EBAP) in recurrent Lymphomas: a Southwest Oncology Group study.
• A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic Leukemia: a Southwest Oncology Group study.
• Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study.
• The combined modality therapy of diffuse histology non-Hodgkin's Lymphoma with cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) and total body irradiation.
• Alternating combination chemotherapy and levamisole improves survival in multiple Myeloma: a Southwest Oncology Group Study.
• Phase II trial of sequential chemotherapy and low-dose radiotherapy in advanced gastric adenocarcinoma. A Southwest Oncology Group Pilot Study.
• Phase II trial of five day intravenous infusion vinblastine sulfate in patients with diffuse malignant mesothelioma: a Southwest Oncology Group study.
• Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's Disease. A Southwest Oncology Group Study.
• Alternated versus syncopated CHOP-PVB: two studies for the treatment of non-Hodgkin's Lymphoma by the Southwest Oncology Group.
• A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated Acute myeloid leukemia: a Sou...
• Extended administration of oral etoposide and oral cyclophosphamide for the treatment of advanced non-small-cell lung Cancer: a Southwest Oncology Group study.
• Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung Cancer: mature results of Southwest Oncolo...
• Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's Lymphoma with MACOP-B: a Southwest Oncology Group study.
• Treatment of recurrent Lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study.
• A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung Cancer: a Southwest Oncology Group study.
• Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in Acute myeloid leukemia: a Southwest On...
• Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's Lymphomas.
• Unfavorable histologies of non-Hodgkin's Lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study.
• Phase II study of carboplatin (CBDCA) in refractory multiple Myeloma. A Southwest Oncology Group study.
• The evaluation of gemcitabine in resistant or relapsing multiple Myeloma, phase II: a Southwest Oncology Group study.

Schools

---

• Ohio State University College of Medicine

• Riverside Methodist Hospital

• Mayo Clinic Rochester

Conditions Treated

---

• Acute Leukemia
• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology
• Internal Medicine

Accepted Insurances

---

Education

---

• Mayo School of Graduate Medical Education
• Riverside Methodist Hospitals - OhioHealth
• The Ohio State University College of Medicine

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Deepak S. Mandi, MD This Doctor is OpenDoctor Recommended.
	Dr. Lorna S. Barclay, MD This Doctor is OpenDoctor Recommended.
	Dr. Shabtab F. Karatela, MD This Doctor is OpenDoctor Recommended.
	Dr. Beverly C. Sicherer, MD This Doctor is OpenDoctor Recommended.
	Dr. Monise M. Maignan, MD This Doctor is OpenDoctor Recommended.
	Dr. Sai V. Bellam, MD This Doctor is OpenDoctor Recommended.
	Dr. Octavious McGill, MD This Doctor is OpenDoctor Recommended.
	Dr. Howard B. Parmet, MD This Doctor is OpenDoctor Recommended.
	Dr. Shakira L. Payne-Blackman, MD
	Dr. Stuart M. Waldman, MD This Doctor is OpenDoctor Recommended.
	Dr. Jose A. Hernandez, MD
	Dr. Michael K. Alleyne, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog